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Background: The process of epithelial-mesenchymal transition (EMT) involves the 
trans-differentiation of epithelial cells to mesenchymal cells associated with high 
plasticity. It usually occurs when the cells acquire migratory and invasive 
characteristics due to the weakening or the loss of cell-cell adhesion.  Human 
chorionic gonadotropin (hCG), a pregnancy hormone, consists of a common α subunit 
which is shared by three other hormones, thyroid stimulating hormone, luteinizing 
hormone and follicular stimulating hormone; and an unique β subunit (hCGβ). 
Previous studies have demonstrated that hCGβ was expressed by some epithelial 
origin cancers (1, 2, 3) and therefore it has been postulated as a possible epithelial 
cancer biomarker. Other studies have linked the presence hCGβ to the aggressive and 
invasive behavior of certain cancers and their poor prognosis (3, 4). 
Methods: This study was set out to investigate whether hCGβ plays a role in inducing 
the EMT and to elucidate the possible pathways.  Human keratinocytes (HK) were 
exposed to spent media collected from hCGβ producing cancer cells (ScaBER cells) 
for 48 hours before the cells were either fixed for immnuostaining or cells were lysed 
and protein extracts were collected for western blotting analysis. The expression of 
epithelial and mesenchymal markers was evaluated by both florescent 
immunocytochemistry and western blotting techniques. 
Results:  A trend of up-regulation of mesenchymal markers (Vimentin and β-catenin) 
and down regulation of epithelial marker (E-cadherin) in these treated HK cells was 
observed. There was 50% increase in cell number which was positively stained by 
anti-Vimentin antibody whilst 16% of the cells have lost E-cadherin expression 
(100% to 84%) following 48 hours’ exposure to the hCGβ containing media. These 
findings were in consistence with the results from HK cells that were exposed to 
recombinant hCGβ (r-hCGβ). It was also observed that the changes in the expressions 
of these markers were reduced when a combination of three anti-hCGβ antibodies 
targeting different hCGβ epitopes was added to the spent media. These results were 
confirmed by western blotting analysis. 
Conclusion: The findings suggest that ectopic hCGβ produced by cancer cells might 
be involved in EMT associated with the migratory and aggressive behavior of such 
cancers. Furthermore, the up-regulation of β-catenin also suggests its possible role in 
the Wnt pathway which offers an insight into EMT process at a molecular level. This 
could be valuable point in developing future novel anti hCGβ therapies for such types 
of cancers. 
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